EP3157527
EZH2 hemlar til meðferðar á eitilæxli
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
17.6.2015EP published:
24.5.2023EP application number:
15809540.6
EP translation filed:
27.6.2023Grant published:
15.8.2023EPO information:
European Patent Register
Max expiry date:
16.6.2035Expiry date:
16.6.2025
Title in English:
EZH2 INHIBITORS FOR TREATING LYMPHOMALanguage of the patent:
English
Timeline
Today
17.6.2015EP application
24.5.2023EP Publication
27.6.2023Translation submitted
15.8.2023Registration published
16.6.2025Expires
Owner
Name:
Epizyme, Inc.Address:
400 Technology Square, 4th Floor, Cambridge, MA 02139, US
Name:
Eisai R&D Management Co., Ltd.Address:
6-10, Koishikawa 4-chome, Bunkyo-ku, Tokyo 112-8088, JP
Inventor
Name:
KEILHACK, HeikeAddress:
Belmont, Massachusetts 02478, US
Name:
OTTESEN, LoneAddress:
London, NW3 2JY, GB
Name:
REYDERMAN, LarisaAddress:
Watchung, NJ 07069, US
Name:
JOHNSTON, L. DanielleAddress:
Cambridge, MA 02139, US
Name:
KNUTSON, Sarah K.Address:
Lincoln, MA 01773, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201462013522 PDate:
17.6.2014Country:
US
Number:
201462036265 PDate:
12.8.2014Country:
US
Classification
Categories:
A61K 31/5377, A61K 31/4412, A61K 31/444, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 9
Paid: 25.9.2023
Expires: 16.6.2024
Payer: Árnason Faktor ehf.
Number: 10
Paid: 7.5.2024
Expires: 16.6.2025
Payer: Árnason Faktor ehf.